The FDA has approved baricitinib for adolescents aged 12 and older with severe alopecia areata, marking the first systemic oral therapy cleared for this population.
News|Poll|February 10, 2016
A Friable Lesion on the Neck of a 15-year-old Boy: Dx?
Author(s)ReelDx
Video: The lesion bleeds easily and grows back quickly when "knocked off."
Advertisement
A 15-year-old boy presents with a friable, rapidly-growing skin lesion that bleeds easily. It has been present for approximately 3 weeks. Video provides a close-up during examination.
Advertisement
Related to this article
Takeda’s oral TYK2 inhibitor showed rapid skin clearance in phase 3 psoriasis trials as FDA fast-tracks review; decision expected early 2027.
Advertisement
Advertisement
Trending on Patient Care Online
1
Beyond Semaglutide and Tirzepatide: The Next Wave of Obesity Medicines
2
FDA Grants Priority Review to Elinzanetant for VMS in HR+ Breast Cancer Patients on Endocrine Therapy
3
FDA Expands Baricitinib Approval to Adolescents With Severe Alopecia Areata
4
Detecting Atrial Fibrillation in Primary Care: Warning Signs and Modifiable Risk Factors
5